Mast prices equity offering; shares off 40%

|By:, SA News Editor

Mast Therapeutics (MSTX -40.2%) prices its public offering of 29,090,910 units at $0.275 per unit. Each unit consists of one share of common stock and one five-year warrant to purchase one share of common at $0.42. Net proceeds will be ~$7.3M. Closing date is February 16.

Net proceeds will fund the clinical development and commercialization of vepoloxamer, working capital and general corporate purposes.

Previously: Mast initiates equity offering (Feb. 9)

Subscribe for full text news in your inbox